Clearmind Medicine Inc. (CMND) Form 6-K — Oct 13, 2026
Clearmind Medicine (Nasdaq: CMND) announced that its 51%-owned subsidiary Charging Robotics has launched the next generation of its autonomous EV charging platform, targeting robotaxis, autonomous fleets, and automated parking facilities. The platform uses resonant inductive power transfer to charge vehicles wirelessly, designed to deliver up to 10 kW at up to 95% efficiency under specified conditions, without plug-in connections or robotic arms. The system also includes AI-driven energy management that schedules and prioritizes charging across multiple vehicles to reduce peak electricity demand.
Key figures
- Granted patents
- 32
- Patent families
- 19
- Efficiency up to
- 95%
- Charging power max
- 10 kW
- Subsidiary ownership percent
- 51
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.